Jul 20 2022

Halberd Corp. Launches “Halberd Cancer Therapeutics, LTD” Wholly Owned Subsidiary

By |2022-07-19T20:21:05-04:00July 20th, 2022|Featured, Investor News, News|0 Comments

Jackson Center, PA, July 20, 2022 – Halberd Corporation (OTC-PINK: "HALB”) announced the formation of Halberd Cancer Therapeutics, LTD, as a wholly owned subsidiary.  Halberd’s patented extracorporeal technology has demonstrated the capacity for successful application to a wide variety of diseases and health-related illnesses.  For now, the new entity will be staffed by Halberd personnel ...

Jul 1 2020

Halberd Establishes UK Subsidiary

By |2020-07-01T10:06:25-04:00July 1st, 2020|Featured, News|0 Comments

Jackson Center, PA, July 1, 2020 – Halberd Corporation (OTC-PINK: "HALB") announced the establishment of a subsidiary in the United Kingdom to facilitate access to European research facilities and markets.  The subsidiary is Halberd Corporation UK, Ltd. William A. Hartman, Chairman, President & CEO of Halberd, stated, “This is the first step in our overall ...

Go to Top